PIH26 COST EFFECTIVENESS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS AMONG EXTREME PRETERM INFANTS (29 WEEKS OF GESTATIONAL AGE) AT THE SOCIAL SECURITY MEXICAN INSTI... von Paladio Hernández, J.Á., Lagunas-Quiroz, J.I., Matías-Juan, N.A.

Volltext

EE433 BUDGET IMPACT ANALYSIS OF GLATIRAMER ACETATE 40MG (DOXELEV®) IN THE TREATMENT OF RELAPSING–REMITTING MULTIPLE SCLEROSIS IN IN MEXICO von Domínguez-Cruces, C., Sanchez, P., Santillán-Montelongo, E., Martínez-Alvarado, I., Godina-Ortiz, B.A., Paladio Hernández, J.Á.

Volltext

PIN39 ECONOMIC EVALUATION OF THE NATIONAL AIDS PLAN RECOMMENDED GUIDELINES FOR COFORMULATED INITIAL ANTIRETROVIRAL THERAPY IN HIV-INFECTED ADULTS IN MEXICO IN 2018 von Paladio Hernández, J.Á., Leal-González, M., Devars-Cleren, E.A., Godina-Ortiz, B.A., Vera-Rendón, P.

Volltext

PCN124 BUDGET IMPACT ANALYSIS OF IMMUNOTHERAPY AS SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AT MEXICO´S NATIONAL INSTITUTE OF CANCER von Barrón-Barrón, F., Meneses-García, A.A., Rivera, L.M., de la Garza-Salazar, J., Cardona, A.F., Arrieta, O.G., Chávez Millan, F., Palafox Torres, D., Paladio Hernández, J.Á.

Volltext

PIN11 Budget IMPACT of the National AIDS PLAN Recommended Guidelines for Preferent NO Coformulated Initial Antiretroviral Therapy in Naïve HIV-Infected Adults in Mexico in 2020 von Leal-González, M., Devars-Cleren, E.A., Godina-Ortiz, B.A., Vera-Rendón, P., Paladio Hernández, J.Á.

Volltext

P2.26 Budget Impact Analysis of Immunotherapy as Second-line Treatment of NSCLC at MX's National Institute of Cancer von Tirado, L.A. Ramírez, Barrón, F., Barron, L. Zatarain, Álvarez, M.P. Peralta, Meneses-García, A.A., Ruíz-Godoy, L.M., De La Garza Salazar, J., Torres, D.I. Palafox, Millan, M.F. Chávez, Hernández, J.Á. Paladio, Cardona, A.F., Arrieta, O.

Volltext

PIN7 ECONOMIC EVALUATION OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (GENVOYA®) AS A COMPLETE TREATMENT REGIMEN FOR HIV-1 INFECTION IN ADULTS WHO ARE ANTIRETROVI... von Paladio Hernández, J.Á., Leal-González, M., Devars-Cleren, E.A., Barrera-Balderas, L.T., Vera-Rendón, P., Godina-Ortiz, B.A.

Volltext

PIN4 A BUDGET IMPACTO ANALYSIS OF TENOFOVIR ALAFENAMIDE/EMTRICITABINE (DESCOVY®) FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN PATIENTS AGED 12 YEAR... von Leal-González, M., Devars-Cleren, E.A., Paladio Hernández, J.Á., Barrera-Balderas, L.T., Vera-Rendón, P., Godina-Ortiz, B.A.

Volltext

PDB23 Economic Impact of Analogue Insulin on Health Expenditure at the Mexican Institute of Social Security in 2012. An Expenditure Reduction Proposal von Panopoulou, P, Garcia-Contreras, F, Paladio-Hernandez, J.A, Huerta, J.L, Gonzalez Pier, E

Volltext

PCN10 - ECONOMIC IMPACT OF MEDICATION ERRORS DETECTED IN ONCOLOGIC INPATIENTS AND OUTPATIENTS IN A MEXICAN HOSPITAL von Morales Perez, M., Paladio-Hernandez, J.A., Luna Mendoza, D., Paredes-Garcia, P., Munguia Juarez, L., Sanchez Rodriguez, I., Lopez-Luis, J., Hernandez-Martinez, J., Ramirez-Padilla, L., Diaz-Rosales, S., Ponce-Rodriguez, M.

Volltext